Cornely M, Henkel E, Trapp H
Fortschr Med. 1978 Oct 5;96(37):1881-6.
The excretion of Piracetam was monitored by measuring the concentrations in maternal and fetal substrates during labor in nine volunteers. Piracetam was tolerated without side-effects and injected in the maternal cubital vein. Consecutively, maternal plasma and urine samples as well as amniotic fluid portions were collected during labor. at delivery, fetal blood from placenta and the first fetal urines were collected. Biostatistical methods showed that approximately 50% of Piracetam were eliminated 80 minutes after the injection of the drug. In amniotic fluid a continuous rise of Piracetam concentrations was monitored until delivery. In fetal plasma and urines the substance could be detected. The rapid excretion of Piracetam during labor was obviously typical for the situation sub partu; reasons are discussed.
通过测量9名志愿者分娩时母体和胎儿样本中的浓度来监测吡拉西坦的排泄情况。吡拉西坦耐受性良好,无副作用,经母体肘静脉注射。分娩过程中,依次采集母体血浆、尿液样本以及羊水样本。分娩时,采集胎盘处的胎儿血液和胎儿的首次尿液。生物统计学方法显示,注射药物80分钟后,约50%的吡拉西坦被清除。在羊水中,监测到吡拉西坦浓度持续上升直至分娩。在胎儿血浆和尿液中可检测到该物质。分娩期间吡拉西坦的快速排泄显然是分娩期的典型情况;对其原因进行了讨论。